12

A leading inhalation expert

Iconovo is a Swedish CDMO company, offering innovative inhalation platforms to the international pharmaceutical industry. We have several types of patented dry powder inhaler devices, and inhouse formulation, for the development of complete inhalation products within both new pharmaceuticals and generic medicine. As a leading inhaler expert, Iconovo is the knowledgeable partner you need to accelerate opportunities and time to market.

Latest news from Iconovo

Iconovo receives positive guidance from FDA regarding substitutability for ICOpre

Iconovo announces that the US Food and Drug Administration (FDA) has issued a positive guidance regarding the generic substitutability of the company's…
Read more

BIOSTOCK: The future of obesity treatment – Iconovo develops intranasal semaglutide

This morning, BIOSTOCK released an article regarding Iconovo's development of an intranasal semaglutide formulation for the treatment of obesity in the…
Read more

Iconovo develops intranasally inhaled semaglutide in ICOone Nasal for more user-friendly treatment of overweight and obesity

Iconovo announced today that the company has initiated the development of the GLP-1 analogue semaglutide in the inhaler ICOone Nasal for intranasal treatment…
Read more
Read all news

Meet us

BUSINESS MEETINGS

NLS Days 

September 17-19, 2024

Malmö

CPhI  

October 8-10, 2024

Milan

MVIC Inhalation Symposium 

October 16-17, 2024

Lund

INVESTOR MEETINGS

Redeye Medtech & Diagnostics 

November 13th

Jefferies London Healthcare Conference

November 19th – 21st, 2024

Redeye Life Science Day 

December 3rd

Carnegie Bolagsdag

December 5th

JP Morgan Health Care Conference 

January 13th – 15th

PARTNERSHIP

Your innovative inhaler partner

We are a specialized CDMO that develops inhalation products in our patented, innovative inhalers, supporting customers in bringing their inhaled treatments to market.

Learn more

PRODUCTS

Four differentiated technical platforms

We develop inhaled medicines from your drug substance as your complete inhalation partner. We take you all the way through your pharmaceutical product development, from idea to finalized inhalation product. Our strength is the integrated development of inhaler and dry powder formulation. Four differentiated technical inhaler platforms can be optimized with your unique dry powder formulation, and we also assist with manufacturing of clinical trial material in early clinical trials and technical documentation for registrations.

Learn more

DEVELOPMENT RESOURCES

Engineering and pharmaceutical expertise

Iconovo has an integrated development process, with all competences and facilities inhouse. With a unique combination of engineering and pharmaceutical expertise, our capabilities include devices, formulation, pharmaceutical analysis, and advisory services.

Learn more

Stay up to date with Iconovo’s news and press releases

SIGN UP